跳至主要内容
临床试验/CTRI/2012/02/002439
CTRI/2012/02/002439招募中未知

An International Study on MRI-guided brachytherapy in locally advanced cervical cancer (EMBRACE) - EMBRACE

Medical University of Vienna0 个研究点目标入组 600 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Cancer of the uterine cervix considered suitable for curative treatment with definitive radio-(chemo)therapy including MRI guided BT
  • Positive biopsy showing squamous-cell carcinoma, adenocarcinoma or adeno-squamous cell carcinoma of the uterine cervix.
  • Staging according to FIGO and TNM guidelines
  • MRI of pelvis at diagnosis is performed
  • MRI, CT or PET-CT of the retroperitoneal space and abdomen at diagnosis is performed
  • MRI with the applicator in place at the time of (first) BT will be performed
  • Para-aortic metastatic nodes below L1-L2 are allowed
  • Patient informed consent

排除标准

  • Other primary malignancies except carcinoma in situ of the cervix and basal cell carcinoma of the skin
  • Metastatic disease beyond para-aortic region (L1-L2)
  • Previous pelvic or abdominal radiotherapy
  • Previous total or partial hysterectomy
  • Combination of preoperative radiotherapy with surgery
  • Patients receiving BT only
  • Patients receiving EBRT only
  • Patients receiving neoadjuvant chemotherapy
  • Contra indications to MRI
  • Contra indications to BT
  • Active infection or severe medical condition endangering treatment delivery
  • Pregnant, lactating or childbearing potential without adequate contraception

研究者

相似试验